EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 27-Jun-2026 01:15 ET (27-Jun-2026 05:15 GMT/UTC)

Targeting MD2 could limit prostate cancer bone metastasis

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — April 1, 2026 — A new research perspective was published in Volume 13 of Oncoscience on March 11, 2026, titled “Targeting MD2 in prostate cancer bone metastasis: Mechanistic insights and therapeutic potential.”

Journal: Oncoscience

Doctors group files legal petition urging USDA to require colorectal cancer warning labels on processed meat

Physicians Committee for Responsible Medicine
Reports and Proceedings

To help protect Americans from colorectal cancer, which is now the leading cause of cancer death for people under 50, the Physicians Committee for Responsible Medicine filed a legal petition today urging the U.S. Department of Agriculture to require warning labels on processed meat and poultry products, such as bacon, deli meat, and hot dogs, which have been classified as “carcinogenic to humans” because of their link to colorectal cancer.

USC physician-scientist Mohamed Abou-el-Enein named Outstanding New Investigator by the American Society of Gene + Cell Therapy

Keck School of Medicine of USC
Grant and Award Announcement

USC physician-scientist Mohamed Abou-el-Enein, MD, PhD, has found himself in a win-win situation: winning not one but two awards from the American Society of Gene + Cell Therapy (ASGCT), the leading professional organization in the field.

The first award celebrates Abou-el-Enein as a 2026 Outstanding New Investigator based on his contributions to the field of gene and cell therapy within the first 10 years of his career as an independent investigator.

The second, the 2026 Best of Molecular Therapy Award, honors a paper from his lab that demonstrates exceptional novelty, innovation and scientific significance. This year’s award recognizes “High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing” by first author Amaia Cadinanos-Garai. Additional authors are Christian L. Flugel, Anson Cheung, Enzi Jiang and Alix Vaissié from the Abou-el-Enein Lab and USC/Children’s Hospital Los Angeles (CHLA) Cell Therapy Program.

Meeting: ASGCT 2026 Annual Meeting

Common metabolic enzyme could predict cancer immunotherapy benefits — and help more patients respond

Rutgers University
Peer-Reviewed Publication

Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for only about 20% of patients, though, and doctors still struggle to predict who will benefit.

A Rutgers Cancer Institute study in Cell Reports Medicine promises help with both those problems. It identifies a protein that appears to predict drug response, and it shows that pairing immunotherapy with a second type of drug dramatically improves survival in mice.

Journal: Cell Reports Medicine

Study of robotic bronchoscopy suggests it's safer, faster path to diagnosing lung cancer

Mayo Clinic
Peer-Reviewed Publication

As lung cancer screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians face a challenge. Most peripheral pulmonary lesions are benign, yet the malignant minority represent the leading cause of cancer death for both men and women. Robotic bronchoscopy may provide a less invasive and more precise approach to diagnosing lung cancer, suggests a five-year, multisite Mayo Clinic study published in Mayo Clinic Proceedings.

Journal: Mayo Clinic Proceedings

New research reveals dangers of ‘anti-aging’ supplements in cancer protection

Case Western Reserve University
Peer-Reviewed Publication

A new study, led by researchers at Case Western Reserve University’s School of Medicine, found that vitamin B3 derivatives may be doing more harm than good—helping cancer cells survive and resist treatment.

Journal: Cancer Letters

Insilico at AACR: Four innovative posters demonstrating the power of generative AI

InSilico Medicine
Meeting Announcement

At AACR 2026, Insilico will unveil four novel cancer inhibitors discovered via its end-to-end Pharma.AI platform. By harnessing trillions of data points and millions of molecular fragments, the platform integrates generative biology for target discovery with generative chemistry for de novo molecular design, accelerating the path from data to drug candidates.

NCCN 2026 Annual Conference prepares cancer care providers worldwide for healing the whole patient

National Comprehensive Cancer Network
Meeting Announcement

NCCN brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in Orlando, Florida, with hundreds more joining virtually. This year’s event featured educational sessions on the latest breakthroughs in cancer prevention and treatment, clinical guidelines updates, guidance for improving cancer center operations, plus panel discussions on critical issues in care delivery.

Meeting: NCCN 2026 Annual Conference

Pesticides and cancer: A study reveals the biological mechanisms behind an environmental health risk

Institut Pasteur
Peer-Reviewed Publication

A new scientific study, published in Nature Health, reveals a strong link between exposure to agricultural pesticides in the environment and the risk of developing cancer. By combining environmental data, a nationwide cancer registry, and biological analyses, researchers from the IRD, the Institut Pasteur, the University of Toulouse, and the National Institute of Neoplastic Diseases (INEN) in Peru have shed new light on the role of pesticide exposure in the development of certain cancers.

Journal: Nature

‘‘Smart’’ drugs to fight cancer

Université de Genève
Peer-Reviewed Publication

How can cancer cells be targeted without damaging healthy tissue? This is one of the major challenges facing oncology today. Using synthetic DNA strands, a team from the University of Geneva (UNIGE) has created a “smart” system that can recognise cancer cells with exceptional precision and release powerful drugs only where they are needed. Beyond cancer treatment, this research paves the way to “smart” medicines and programmable drug delivery. The full article can be discovered in the latest issue of Nature Biotechnology.

Journal: Nature Biotechnology